Quick Heal Tech

Is Quick Heal Tech overvalued or undervalued?

As of February 5, 2025, Quick Heal Technologies Ltd. is considered overvalued with a PE ratio of 393.95 and negative EV to EBITDA, indicating significant profitability concerns and unfavorable comparisons to peers, despite a recent stock price surge.

As of 5 February 2025, Quick Heal Technologies Ltd. has moved from a valuation grade of very expensive to risky, indicating a significant shift in its market perception. The company is currently considered overvalued, particularly highlighted by its PE ratio of 393.95 and an EV to EBITDA ratio of -272.02, which suggests severe profitability concerns. Additionally, the ROCE stands at -7.86%, further emphasizing the challenges the company faces in generating returns on capital.<BR><BR>In comparison to its peers, Quick Heal's valuation metrics are starkly unfavorable; for instance, its PE ratio is substantially higher than industry averages, while its EV to EBITDA is negative, indicating potential operational inefficiencies. Notably, the company’s PEG ratio is 0.00, which raises questions about future growth prospects. Despite a recent surge in stock price, with a 1-week return of 22.18% compared to the Sensex's 1.38%, the overall valuation suggests that Quick Heal Technologies Ltd. remains overvalued in the current market landscape.

Who are in the management team of Quick Heal Tech?

As of March 2022, the management team of Quick Heal Tech includes Kailash Katkar (Managing Director & CEO), Sanjay Katkar (Joint Managing Director & CTO), and several independent directors, contributing diverse expertise to the company's strategic and operational management.

As of March 2022, the management team of Quick Heal Tech includes:<BR><BR>1. Kailash Sahebrao Katkar - Managing Director & CEO<BR>2. Sanjay Sahebrao Katkar - Joint Managing Director & CTO<BR>3. Shailesh Lakhani - Director<BR>4. Apurva Pradeep Joshi - Independent Director<BR>5. Amitabha Mukhopadhyay - Independent Director<BR>6. Bhushan Gokhale - Independent Director<BR>7. Srinivasa Rao Anasingaraju - Company Secretary & Compliance Officer<BR>8. Richard Stiennon - Independent Director<BR><BR>This team brings a diverse range of expertise to the company, contributing to its strategic direction and operational management.

Has Quick Heal Tech declared dividend?

Quick Heal Technologies Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of August 30, 2024. While recent returns have been negative, the company has shown significant growth over the longer term, particularly a total return of 243.34% over the past 5 years.

Quick Heal Technologies Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 30 Aug 24<BR><BR>Dividend Yield: 0.82%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -45.2%, with a dividend return of 0%, resulting in a total return of -45.2%.<BR><BR>Over the past year, the price return was -21.75%, the dividend return was 0.69%, leading to a total return of -21.06%.<BR><BR>In the 2-year period, the price return was 118.34%, the dividend return was 3.43%, culminating in a total return of 121.77%.<BR><BR>For the 3-year period, the price return was 105.86%, the dividend return was 6.71%, resulting in a total return of 112.57%.<BR><BR>In the last 4 years, the price return was 51.9%, with a dividend return of 5.15%, leading to a total return of 57.05%.<BR><BR>Over the past 5 years, the price return was 231.23%, the dividend return was 12.11%, resulting in a total return of 243.34%.<BR><BR>Overall, Quick Heal Technologies Ltd has declared a dividend, and while the recent returns over shorter periods have been negative, the longer-term returns show significant growth, particularly in the 5-year period.

Who are the peers of the Quick Heal Tech?

Quick Heal Tech's peers include C.E. Info System, Tanla Platforms, Moschip Tech, Nucleus Soft, Technvision Ven, Blue Cloud Soft, Ramco Systems, Unicommerce, IRIS Business, and Subex. Notably, IRIS Business has the highest 1-year return at 47.93%, while Blue Cloud Soft has the lowest at -85.59%.

Peers: The peers of Quick Heal Tech are C.E. Info System, Tanla Platforms, Moschip Tech., Nucleus Soft., Technvision Ven., Blue Cloud Soft., Ramco Systems, Unicommerce, IRIS Business, and Subex.<BR><BR>Quality Snapshot: Excellent management risk is observed at C.E. Info System, Nucleus Soft., and Unicommerce, while Average management risk is found at Tanla Platforms, Technvision Ven., Blue Cloud Soft., Ramco Systems, IRIS Business, and Subex. Good growth is noted at C.E. Info System, Tanla Platforms, Unicommerce, and the rest have either Below Average or Average growth. Excellent capital structure is seen at C.E. Info System, Nucleus Soft., Technvision Ven., Unicommerce, and IRIS Business, while Average capital structure is found at Blue Cloud Soft. and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is IRIS Business at 47.93%, while the peer with the lowest is Blue Cloud Soft. at -85.59%. Quick Heal Tech's 1-year return of -28.50% is better than Blue Cloud Soft. but worse than IRIS Business. Additionally, the six-month return is negative for Moschip Tech., Blue Cloud Soft., and Subex.

What does Quick Heal Tech do?

Quick Heal Technologies Ltd is a small-cap company specializing in cybersecurity solutions, with a recent net sales of 651 Cr and a net profit of -32 Cr as of March 2025. The company has a market cap of INR 2,074 Cr and operates with a P/E ratio of 423.00.

Overview:<BR>Quick Heal Technologies Ltd is a small-cap company operating in the Software Products industry, specializing in cybersecurity solutions.<BR><BR>History:<BR>Quick Heal Technologies Limited was incorporated in 1995 as CAT Computer Services Private Limited and later changed its name in 2007. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 651 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -32 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 2,074 Cr (Small Cap) <BR><BR>Key Metrics:<BR>P/E: 423.00 <BR>Industry P/E: 29 <BR>Dividend Yield: 0.78% <BR>Debt-Equity: -0.44 <BR>Return on Equity: 1.14% <BR>Price to Book: 4.66 <BR><BR>Contact Details:<BR>Address: Marvel Edge 7th Floor, Office No 7010 C&D Viman Nagar Pune Maharashtra : 411014 <BR>Tel: 91-20-66813232 <BR>Email: cs@quickheal.com <BR>Website: http://www.quickheal.com

Who are the top shareholders of the Quick Heal Tech?

The top shareholder of Quick Heal Tech is Sanjay Sahebrao Katkar, holding 28.86%. Other notable shareholders include 22 foreign institutional investors with 2.02%, a mutual fund with 1.13%, and individual investors collectively holding 19.14%.

The top shareholders of Quick Heal Tech include the promoters, with Sanjay Sahebrao Katkar holding the largest share at 28.86%. There are no pledged promoter holdings. Additionally, institutional investors include 22 foreign institutional investors (FIIs) who collectively hold 2.02%, and one mutual fund scheme that holds 1.13%. Among public shareholders, the highest holding is by Carnelian Structural Shift Fund at 1.22%. Individual investors collectively hold 19.14% of the company.

How big is Quick Heal Tech?

As of 24th July, Quick Heal Technologies Ltd has a market capitalization of 1,820.00 Cr, with recent net sales of 279.53 Cr and a net profit of 5.04 Cr. Shareholder's funds are 437.00 Cr, and total assets amount to 509.23 Cr.

As of 24th July, Quick Heal Technologies Ltd has a market capitalization of 1,820.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 279.53 Cr and a Net Profit of 5.04 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 437.00 Cr and Total Assets of 509.23 Cr.

When is the next results date for Quick Heal Tech?

The next results date for Quick Heal Tech is 15 October 2025.

The next results date for Quick Heal Tech is scheduled for 15 October 2025.

How has been the historical performance of Quick Heal Tech?

Quick Heal Tech has experienced a significant decline in financial performance, with net sales dropping from INR 341.90 crore in March 2022 to INR 279.53 crore in March 2025, and operating profit turning negative at -INR 6.59 crore. Key metrics such as profit before tax and earnings per share have also sharply decreased during this period.

Answer:<BR>The historical performance of Quick Heal Tech shows a fluctuating trend in key financial metrics over the years, with significant declines in recent periods.<BR><BR>Breakdown:<BR>Quick Heal Tech's net sales have seen a decline from INR 341.90 crore in March 2022 to INR 279.53 crore in March 2025, with a slight recovery from INR 278.09 crore in March 2023. The total operating income followed a similar pattern, peaking at INR 341.90 crore in March 2022 and dropping to INR 279.53 crore by March 2025. The company's total expenditure, excluding depreciation, increased from INR 235.04 crore in March 2022 to INR 286.12 crore in March 2025, contributing to an operating profit (PBDIT) that turned negative at -INR 6.59 crore in March 2025, down from a high of INR 126.06 crore in March 2022. Profit before tax also fell sharply from INR 108.68 crore in March 2022 to INR 1.00 crore in March 2025, while profit after tax decreased from INR 83.19 crore to INR 5.04 crore in the same period. The earnings per share (EPS) reflected this downturn, dropping from INR 14.34 in March 2022 to INR 0.93 in March 2025. On the balance sheet, total assets decreased from INR 715.88 crore in March 2022 to INR 517.10 crore in March 2025, while total liabilities also decreased from INR 715.88 crore to INR 517.10 crore, indicating a consistent reduction in both assets and liabilities. The cash flow from operating activities turned negative at -INR 22.00 crore in March 2025, contrasting with positive cash flows in earlier years. Overall, Quick Heal Tech has experienced a significant decline in financial performance over the past few years.

Is Quick Heal Tech technically bullish or bearish?

As of December 2, 2025, Quick Heal Tech's technical stance is bearish with moderate strength, driven by bearish signals from moving averages and Bollinger Bands, despite some mildly bullish indicators, and a significant year-to-date decline of 54.12% compared to the Sensex's 8.96%.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Quick Heal Tech is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages and the weekly Bollinger Bands, alongside a bearish monthly MACD. Although the weekly MACD and KST show mildly bullish tendencies, the overall monthly indicators remain bearish, reinforcing the bearish outlook. The stock's recent performance, with a significant year-to-date decline of 54.12% compared to the Sensex's 8.96%, further supports this bearish sentiment.

Are Quick Heal Technologies Ltd latest results good or bad?

Quick Heal Technologies Ltd's latest results show a return to profitability with a net profit of ₹6.61 crores, a significant year-on-year increase. However, revenue declined by 14.34% from the previous quarter, raising concerns about stability and reliance on non-operating income, indicating ongoing operational challenges.

Quick Heal Technologies Ltd's latest results present a mixed picture. On one hand, the company has achieved a significant year-on-year increase in net profit, reporting ₹6.61 crores for Q3 FY26, which is a remarkable improvement of 5,909.09% compared to the same quarter last year. This marks a return to profitability after a period of losses.<BR><BR>However, the revenue figures tell a different story. The company reported revenue of ₹71.54 crores for the quarter, which represents a decline of 14.34% compared to the previous quarter. While there was a slight year-on-year growth of 1.32%, the sequential drop raises concerns about revenue stability.<BR><BR>Additionally, the operating margin, excluding other income, was just 0.63%, indicating that the core business is struggling to generate adequate profits. The company's profitability heavily relies on other income, which constituted a significant portion of its profit before tax.<BR><BR>Overall, while the return to profitability is a positive development, the volatility in revenue and reliance on non-operating income highlight ongoing operational challenges. Investors may view these results as a cautious sign, but the underlying issues suggest that the company still faces significant hurdles in achieving consistent growth.

Should I buy, sell or hold Quick Heal Technologies Ltd?

Which are the latest news on Quick Heal Tech?

Why is Quick Heal Technologies Ltd falling/rising?

As of 08-May, Quick Heal Technologies Ltd's stock price has risen by 19.46% to Rs 214.25, driven by strong short-term trading dynamics and increased investor interest, despite long-term challenges in net sales and profitability. The stock has outperformed its sector and has shown consistent gains over the past three days.

As of 08-May, Quick Heal Technologies Ltd is experiencing a significant rise in its stock price, which has increased by 34.9 points, or 19.46%, reaching a current price of Rs 214.25. This upward movement can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has outperformed its sector by 19.17% today, indicating strong relative performance. Additionally, it has been on a positive trend, gaining for the last three consecutive days and accumulating a total return of 31.74% during this period. The stock also reached an intraday high of Rs 215.2, reflecting strong buying interest.<BR><BR>Moreover, there has been a notable increase in investor participation, with delivery volume on 07 May rising by 582.53% compared to the five-day average. This surge in trading activity suggests heightened interest and confidence among investors. The stock is also trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average, indicating a short-term bullish trend.<BR><BR>Despite these positive indicators, it is important to note that the company has faced challenges in the long term, including negative growth in net sales and operating profit over the past five years, as well as a negative EBITDA. However, the current rise in stock price appears to be driven by short-term trading dynamics and increased investor engagement rather than long-term fundamentals.